The iPEP® with PocketPEP® Advantage is a prescription two-in-one device that combines incentive spirometry with oscillating positive expiratory pressure therapy (OPEP), the only two-in-one product on the market.
Studies indicate superior performance in secretion clearance
The PocketPEP® Advantage is the smallest OPEP available, less than half the size of other products, making patients more likely to continue with use on a regular basis
Reduce patient length of stay in acute settings when OPEP therapy is used by mobilizing secretions and reducing the risk atelectasis
Reduce risk of pulmonary complications post discharge with continued use of the convenient OPEP therapy at home
With only one moving part, the PocketPEP® Advantage is easy for patients to operate and clean
The PocketPEP® Advantage is available separately and as part of the iPEP®
The patented PocketPEP Advantage is designed to attach securely to standard Incentive Spirometers or it can also be used independently
The PocketPEP Advantage enables clinicians to set a volume target and measure the patient’s slow inspiratory breath volume unlike traditional OPEP therapy which lacks the capacity to measure volume
The slow inspiratory breath combined with the PocketPEP enhances Expiratory Flow Bias (EFB), proven to mobilize secretions more effectively.
Pursley, D.M. Effect of inspiratory time on PEF/PIF ratio in Three oscillating PEP devices in an adult chronic bronchitis model. Respiratory Therapy 2018; Volume 13, No. 1, 51-54.
Pursley, D.M. Analysis of Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing. Respiratory Therapy 2017; Volume 12, No. 1, 52-56.
Hess, Dean. Respiratory Care: Principles and Practice. Sudbury, MA: Jones & Bartlett Learning, 2016. Print.
U.S. Patent 10,004,872 B1 and other patents pending.
